Global and Japan RNA-Targeted Small Molecules Market Size, Status and Forecast 2023-2027

Report ID: 1127750 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 mRNA Translation Regulation
        1.2.3 RNA Splicing Modification
        1.2.4 Direct RNA Targeting
        1.2.5 Indirect RNA Targeting - Epitranscriptomics
    1.3 Market by Application
        1.3.1 Global RNA-Targeted Small Molecules Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Laboratories
        1.3.4 Phamacy
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global RNA-Targeted Small Molecules Market Perspective (2016-2027)
    2.2 RNA-Targeted Small Molecules Growth Trends by Regions
        2.2.1 RNA-Targeted Small Molecules Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 RNA-Targeted Small Molecules Historic Market Share by Regions (2016-2021)
        2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027)
    2.3 RNA-Targeted Small Molecules Industry Dynamic
        2.3.1 RNA-Targeted Small Molecules Market Trends
        2.3.2 RNA-Targeted Small Molecules Market Drivers
        2.3.3 RNA-Targeted Small Molecules Market Challenges
        2.3.4 RNA-Targeted Small Molecules Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
        3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2016-2021)
        3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2016-2021)
    3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
    3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
        3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2020
    3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
    3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
    3.7 Date of Enter into RNA-Targeted Small Molecules Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 RNA-Targeted Small Molecules Breakdown Data by Type
    4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2016-2021)
    4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027)

5 RNA-Targeted Small Molecules Breakdown Data by Application
    5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2016-2021)
    5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America RNA-Targeted Small Molecules Market Size (2016-2027)
    6.2 North America RNA-Targeted Small Molecules Market Size by Type
        6.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
        6.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
        6.2.3 North America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
    6.3 North America RNA-Targeted Small Molecules Market Size by Application
        6.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
        6.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
        6.3.3 North America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
    6.4 North America RNA-Targeted Small Molecules Market Size by Country
        6.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
        6.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe RNA-Targeted Small Molecules Market Size (2016-2027)
    7.2 Europe RNA-Targeted Small Molecules Market Size by Type
        7.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021)
        7.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027)
        7.2.3 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2027)
    7.3 Europe RNA-Targeted Small Molecules Market Size by Application
        7.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021)
        7.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027)
        7.3.3 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2027)
    7.4 Europe RNA-Targeted Small Molecules Market Size by Country
        7.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021)
        7.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2016-2027)
    8.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type
        8.2.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2027)
    8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application
        8.3.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2027)
    8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region
        8.4.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America RNA-Targeted Small Molecules Market Size (2016-2027)
    9.2 Latin America RNA-Targeted Small Molecules Market Size by Type
        9.2.1 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
        9.2.2 Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
        9.2.3 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
    9.3 Latin America RNA-Targeted Small Molecules Market Size by Application
        9.3.1 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
        9.3.2 Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
        9.3.3 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
    9.4 Latin America RNA-Targeted Small Molecules Market Size by Country
        9.4.1 Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
        9.4.2 Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2016-2027)
    10.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
        10.2.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2027)
    10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
        10.3.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2027)
    10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
        10.4.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Accent Therapeutics
        11.1.1 Accent Therapeutics Company Details
        11.1.2 Accent Therapeutics Business Overview
        11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
        11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.1.5 Accent Therapeutics Recent Development
    11.2 Anima Biotech Inc.
        11.2.1 Anima Biotech Inc. Company Details
        11.2.2 Anima Biotech Inc. Business Overview
        11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
        11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.2.5 Anima Biotech Inc. Recent Development
    11.3 Arrakis Pharmaceuticals
        11.3.1 Arrakis Pharmaceuticals Company Details
        11.3.2 Arrakis Pharmaceuticals Business Overview
        11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
        11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.3.5 Arrakis Pharmaceuticals Recent Development
    11.4 Epics Therapeutics
        11.4.1 Epics Therapeutics Company Details
        11.4.2 Epics Therapeutics Business Overview
        11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
        11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.4.5 Epics Therapeutics Recent Development
    11.5 Expansion Therapeutics
        11.5.1 Expansion Therapeutics Company Details
        11.5.2 Expansion Therapeutics Business Overview
        11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
        11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.5.5 Expansion Therapeutics Recent Development
    11.6 Gotham Therapeutics
        11.6.1 Gotham Therapeutics Company Details
        11.6.2 Gotham Therapeutics Business Overview
        11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
        11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.6.5 Gotham Therapeutics Recent Development
    11.7 H3 Biomedicine
        11.7.1 H3 Biomedicine Company Details
        11.7.2 H3 Biomedicine Business Overview
        11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
        11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.7.5 H3 Biomedicine Recent Development
    11.8 Ribometrix
        11.8.1 Ribometrix Company Details
        11.8.2 Ribometrix Business Overview
        11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
        11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.8.5 Ribometrix Recent Development
    11.9 Skyhawk Therapeutics
        11.9.1 Skyhawk Therapeutics Company Details
        11.9.2 Skyhawk Therapeutics Business Overview
        11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
        11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.9.5 Skyhawk Therapeutics Recent Development
    11.10 STORM Therapeutics
        11.10.1 STORM Therapeutics Company Details
        11.10.2 STORM Therapeutics Business Overview
        11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
        11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.10.5 STORM Therapeutics Recent Development
    11.11 Twentyeight-Seven Therapeutics
        11.11.1 Twentyeight-Seven Therapeutics Company Details
        11.11.2 Twentyeight-Seven Therapeutics Business Overview
        11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
        11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
        11.11.5 Twentyeight-Seven Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of mRNA Translation Regulation
    Table 3. Key Players of RNA Splicing Modification
    Table 4. Key Players of Direct RNA Targeting
    Table 5. Key Players of Indirect RNA Targeting - Epitranscriptomics
    Table 6. Global RNA-Targeted Small Molecules Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global RNA-Targeted Small Molecules Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global RNA-Targeted Small Molecules Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global RNA-Targeted Small Molecules Market Share by Regions (2016-2021)
    Table 10. Global RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global RNA-Targeted Small Molecules Market Share by Regions (2022-2027)
    Table 12. RNA-Targeted Small Molecules Market Trends
    Table 13. RNA-Targeted Small Molecules Market Drivers
    Table 14. RNA-Targeted Small Molecules Market Challenges
    Table 15. RNA-Targeted Small Molecules Market Restraints
    Table 16. Global RNA-Targeted Small Molecules Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global RNA-Targeted Small Molecules Market Share by Players (2016-2021)
    Table 18. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Targeted Small Molecules as of 2020)
    Table 19. Ranking of Global Top RNA-Targeted Small Molecules Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by RNA-Targeted Small Molecules Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players RNA-Targeted Small Molecules Product Solution and Service
    Table 23. Date of Enter into RNA-Targeted Small Molecules Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2016-2021)
    Table 27. Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global RNA-Targeted Small Molecules Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2016-2021)
    Table 31. Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Accent Therapeutics Company Details
    Table 64. Accent Therapeutics Business Overview
    Table 65. Accent Therapeutics RNA-Targeted Small Molecules Product
    Table 66. Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 67. Accent Therapeutics Recent Development
    Table 68. Anima Biotech Inc. Company Details
    Table 69. Anima Biotech Inc. Business Overview
    Table 70. Anima Biotech Inc. RNA-Targeted Small Molecules Product
    Table 71. Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 72. Anima Biotech Inc. Recent Development
    Table 73. Arrakis Pharmaceuticals Company Details
    Table 74. Arrakis Pharmaceuticals Business Overview
    Table 75. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product
    Table 76. Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 77. Arrakis Pharmaceuticals Recent Development
    Table 78. Epics Therapeutics Company Details
    Table 79. Epics Therapeutics Business Overview
    Table 80. Epics Therapeutics RNA-Targeted Small Molecules Product
    Table 81. Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 82. Epics Therapeutics Recent Development
    Table 83. Expansion Therapeutics Company Details
    Table 84. Expansion Therapeutics Business Overview
    Table 85. Expansion Therapeutics RNA-Targeted Small Molecules Product
    Table 86. Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 87. Expansion Therapeutics Recent Development
    Table 88. Gotham Therapeutics Company Details
    Table 89. Gotham Therapeutics Business Overview
    Table 90. Gotham Therapeutics RNA-Targeted Small Molecules Product
    Table 91. Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 92. Gotham Therapeutics Recent Development
    Table 93. H3 Biomedicine Company Details
    Table 94. H3 Biomedicine Business Overview
    Table 95. H3 Biomedicine RNA-Targeted Small Molecules Product
    Table 96. H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 97. H3 Biomedicine Recent Development
    Table 98. Ribometrix Company Details
    Table 99. Ribometrix Business Overview
    Table 100. Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 101. Ribometrix Recent Development
    Table 102. Skyhawk Therapeutics Company Details
    Table 103. Skyhawk Therapeutics Business Overview
    Table 104. Skyhawk Therapeutics RNA-Targeted Small Molecules Product
    Table 105. Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 106. Skyhawk Therapeutics Recent Development
    Table 107. STORM Therapeutics Company Details
    Table 108. STORM Therapeutics Business Overview
    Table 109. STORM Therapeutics RNA-Targeted Small Molecules Product
    Table 110. STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 111. STORM Therapeutics Recent Development
    Table 112. Twentyeight-Seven Therapeutics Company Details
    Table 113. Twentyeight-Seven Therapeutics Business Overview
    Table 114. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product
    Table 115. Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021) & (US$ Million)
    Table 116. Twentyeight-Seven Therapeutics Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global RNA-Targeted Small Molecules Market Share by Type: 2020 VS 2027
    Figure 2. mRNA Translation Regulation Features
    Figure 3. RNA Splicing Modification Features
    Figure 4. Direct RNA Targeting Features
    Figure 5. Indirect RNA Targeting - Epitranscriptomics Features
    Figure 6. Global RNA-Targeted Small Molecules Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Laboratories Case Studies
    Figure 9. Phamacy Case Studies
    Figure 10. RNA-Targeted Small Molecules Report Years Considered
    Figure 11. Global RNA-Targeted Small Molecules Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global RNA-Targeted Small Molecules Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global RNA-Targeted Small Molecules Market Share by Regions: 2020 VS 2027
    Figure 14. Global RNA-Targeted Small Molecules Market Share by Regions (2022-2027)
    Figure 15. Global RNA-Targeted Small Molecules Market Share by Players in 2020
    Figure 16. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Targeted Small Molecules as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by RNA-Targeted Small Molecules Revenue in 2020
    Figure 18. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2016-2021)
    Figure 19. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2022-2027)
    Figure 20. North America RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America RNA-Targeted Small Molecules Market Share by Type (2016-2027)
    Figure 22. North America RNA-Targeted Small Molecules Market Share by Application (2016-2027)
    Figure 23. North America RNA-Targeted Small Molecules Market Share by Country (2016-2027)
    Figure 24. United States RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe RNA-Targeted Small Molecules Market Share by Type (2016-2027)
    Figure 28. Europe RNA-Targeted Small Molecules Market Share by Application (2016-2027)
    Figure 29. Europe RNA-Targeted Small Molecules Market Share by Country (2016-2027)
    Figure 30. Germany RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific RNA-Targeted Small Molecules Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific RNA-Targeted Small Molecules Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific RNA-Targeted Small Molecules Market Share by Region (2016-2027)
    Figure 40. China RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America RNA-Targeted Small Molecules Market Share by Type (2016-2027)
    Figure 48. Latin America RNA-Targeted Small Molecules Market Share by Application (2016-2027)
    Figure 49. Latin America RNA-Targeted Small Molecules Market Share by Country (2016-2027)
    Figure 50. Mexico RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa RNA-Targeted Small Molecules Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa RNA-Targeted Small Molecules Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa RNA-Targeted Small Molecules Market Share by Country (2016-2027)
    Figure 56. Turkey RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE RNA-Targeted Small Molecules Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Accent Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 60. Anima Biotech Inc. Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 61. Arrakis Pharmaceuticals Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 62. Epics Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 63. Expansion Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 64. Gotham Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 65. H3 Biomedicine Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 66. Ribometrix Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 67. Skyhawk Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 68. STORM Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 69. Twentyeight-Seven Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Accent Therapeutics
Anima Biotech Inc.
Arrakis Pharmaceuticals
Epics Therapeutics
Expansion Therapeutics
Gotham Therapeutics
H3 Biomedicine
Ribometrix
Skyhawk Therapeutics
STORM Therapeutics
Twentyeight-Seven Therapeutics
Frequently Asked Questions
RNA-Targeted Small Molecules report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
RNA-Targeted Small Molecules report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
RNA-Targeted Small Molecules report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports